类风湿关节炎与肺癌风险:荟萃分析与孟德尔随机化研究
该研究通过荟萃分析11项队列研究(183,888例患者)发现类风湿关节炎(RA)患者肺癌风险升高(RR=1.44,95%CI 1.31-1.57)。但两样本孟德尔随机化分析显示,遗传预测的RA与肺癌风险整体降低相关,且仅在东亚人群中显著,欧洲人群无此关联。结论认为观察性关联可能受混杂影响,不支持RA与肺癌的因果关联。
要点
- 荟萃分析显示RA患者肺癌风险升高(RR=1.44,95%CI 1.31-1.57)。
- 孟德尔随机化未支持遗传预测RA与肺癌风险的因果关联。
- 遗传预测RA与肺癌风险降低的关联仅在东亚人群显著。
核心结论
- 荟萃分析提示RA与较高的肺癌风险相关,但孟德尔随机化研究不支持遗传预测RA与肺癌风险存在因果关联。
研究设计与样本
- 系统检索队列研究进行荟萃分析(PROSPERO ID CRD42020159082),计算相对风险(RR)及95%置信区间(95%CI)。
- 基于国际肺癌联盟汇总数据(11,348例病例和15,861例对照)及90个RA相关单核苷酸多态性作为工具变量,进行两样本孟德尔随机化分析。
主要发现
- 荟萃分析纳入11项队列研究共183,888例患者,RA患者肺癌风险升高(RR=1.44,95%CI 1.31-1.57)。
- 亚组分析提示男性患者肺癌风险相对高于女性,且1950至2010年间RA患者肺癌发病率增加。
- 孟德尔随机化分析发现遗传预测RA与肺癌风险整体降低相关,但与肺腺癌或肺鳞癌风险均无因果关联。
- 遗传预测RA与肺癌风险降低的关联在东亚人群中显著,在欧洲人群中不显著。
关键数值与推荐
- 荟萃分析中RA患者肺癌风险RR=1.44(95%CI 1.31-1.57)。
- 孟德尔随机化分析使用90个RA相关单核苷酸多态性作为工具变量。
临床怎么用
- 观察性证据提示RA患者肺癌风险较高,临床需关注RA患者的肺癌筛查与监测。
- 孟德尔随机化结果提示遗传预测RA与肺癌风险无因果关联,解读观察性关联时需考虑混杂因素。
局限性
- 孟德尔随机化分析中遗传预测RA与肺癌风险的关联仅在东亚人群显著,欧洲人群不显著,人群差异需进一步验证。
- 观察性研究间的异质性及未测量混杂可能影响荟萃分析结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Observational studies suggest that rheumatoid arthritis (RA) may be associated with lung cancer (LC) risk, while the evidence is inconsistent. We conducted a meta-analysis and a Mendelian randomization study to investigate the association and causality between RA and the LC risk. METHODS: We conducted a systematic search of cohort studies and performed a meta-analysis (PROSPERO ID CRD42020159082) to calculate the relative risks (RRs) and their 95% confidence intervals (95%CIs). Subgroup analyses based on sex and initiation year of follow-up were carried out. E-values of each study were calculated to evaluate if existing studies were sensitive to unmeasured confounding. Furthermore, we investigated the correlation between genetically predisposed RA and LC risk using summary statistics from the International Lung Cancer Consortium (11,348 cases and 15,861 controls) and 90 RA-related single nucleotide polymorphisms from European and East Asian descent as instrumental variables. A two-sample Mendelian randomization (MR) analysis was performed to detect the findings based on LC and histological subtypes. Sensitivity analyses were performed to test the robustness of our findings. RESULTS: In the meta-analysis of 11 cohort studies involving 183,888 patients, an increased risk of LC was observed among RA patients (RR = 1.44, 95%CI = 1.31-1.57). Subgroup analyses suggested that male patients have a relatively higher LC risk than female patients, and an increased incidence of LC in RA patients was found from 1950 to 2010. Conversely, in the MR analysis, we found that genetically predisposed RA was associated with a decreased risk of LC overall, while neither causally associated with the risk of lung adenocarcinoma nor squamous cell lung cancer. Nevertheless, genetically predisposed RA was associated with a decreased LC risk among the East Asian population, but not in Europeans. These results were robust against extensive sensitivity analyses. CONCLUSION: Our meta-analysis suggested that although RA was associated with a relatively higher LC risk, the causal relationship between genetically predisposed RA and LC risk was not supported by the MR study. Further studies are warranted to elucidate the possible association between RA and the risk of LC, as well as its underlying mechanisms.
引用
- Wu X, Peng H, Wen Y, et al. Rheumatoid arthritis and risk of lung cancer: Meta-analysis and Mendelian randomization study. Semin Arthritis Rheum. 2021. PMID: 33932788. doi:10.1016/j.semarthrit.2021.03.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。